Ioannou, A., et al
[email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Telehealth, cash pay, and compounding pharmacies functioned as a scalable distribution system for GLP-1s, filling a supply and access gap for a blockbuster therapy
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective anti-glycemic and weight-loss medications with a strong safety record
Thats why we offer evidence-based treatments such as PRF, exosome therapy, and peptide-based solutions like GHK-Cu, all tailored to your unique biology and lifestyle
For those managing blood sugar, this could be a simple way to blunt post-meal glucose spikes without eliminating carbs altogether